These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20381852)

  • 1. A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease.
    Marwick JA; Caramori G; Casolari P; Mazzoni F; Kirkham PA; Adcock IM; Chung KF; Papi A
    J Allergy Clin Immunol; 2010 May; 125(5):1146-53. PubMed ID: 20381852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice.
    Marwick JA; Caramori G; Stevenson CS; Casolari P; Jazrawi E; Barnes PJ; Ito K; Adcock IM; Kirkham PA; Papi A
    Am J Respir Crit Care Med; 2009 Apr; 179(7):542-8. PubMed ID: 19164702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD.
    Ngkelo A; Hoffmann RF; Durham AL; Marwick JA; Brandenburg SM; de Bruin HG; Jonker MR; Rossios C; Tsitsiou E; Caramori G; Contoli M; Casolari P; Monaco F; Andò F; Speciale G; Kilty I; Chung KF; Papi A; Lindsay MA; Ten Hacken NH; van den Berge M; Timens W; Barnes PJ; van Oosterhout AJ; Adcock IM; Kirkham PA; Heijink IH
    Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1112-23. PubMed ID: 26320152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.
    Löfdahl JM; Wahlström J; Sköld CM
    Clin Exp Immunol; 2006 Sep; 145(3):428-37. PubMed ID: 16907910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease.
    Chana KK; Fenwick PS; Nicholson AG; Barnes PJ; Donnelly LE
    J Allergy Clin Immunol; 2014 Jan; 133(1):207-16.e1-11. PubMed ID: 24176116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease.
    To Y; Ito K; Kizawa Y; Failla M; Ito M; Kusama T; Elliott WM; Hogg JC; Adcock IM; Barnes PJ
    Am J Respir Crit Care Med; 2010 Oct; 182(7):897-904. PubMed ID: 20224070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
    Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of phosphatidylinositol-3 kinase inhibition on matrix metalloproteinase-9 and reactive oxygen species release from chronic obstructive pulmonary disease neutrophils.
    Gupta V; Khan A; Higham A; Lemon J; Sriskantharajah S; Amour A; Hessel EM; Southworth T; Singh D
    Int Immunopharmacol; 2016 Jun; 35():155-162. PubMed ID: 27049289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages.
    Armstrong J; Sargent C; Singh D
    Clin Exp Immunol; 2009 Oct; 158(1):74-83. PubMed ID: 19737233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of the anti-inflammatory effects and a potential biomarker of PI3Kδ inhibition in COPD T cells.
    Khan A; Southworth T; Worsley S; Sriskantharajah S; Amour A; Hessel EM; Singh D
    Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):932-940. PubMed ID: 28508433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers.
    Zhang J; Chu S; Zhong X; Lao Q; He Z; Liang Y
    Int Immunopharmacol; 2013 Jan; 15(1):58-66. PubMed ID: 23127823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
    Knobloch J; Hag H; Jungck D; Urban K; Koch A
    Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced glucocorticoid receptor expression and function in airway neutrophils.
    Plumb J; Gaffey K; Kane B; Malia-Milanes B; Shah R; Bentley A; Ray D; Singh D
    Int Immunopharmacol; 2012 Jan; 12(1):26-33. PubMed ID: 22032841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases.
    Sriskantharajah S; Hamblin N; Worsley S; Calver AR; Hessel EM; Amour A
    Ann N Y Acad Sci; 2013 Mar; 1280():35-9. PubMed ID: 23551101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of hypoxia-inducible factor-1α in patients with chronic obstructive pulmonary disease and smokers with normal lung function].
    Tao H; Luo W; Pei H; Zhu S; Zhang M; Chen B; He J; Zhang M; Zhou R
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):852-5. PubMed ID: 25108440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
    Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches.
    Marwick JA; Adcock IM; Chung KF
    Drugs; 2010 May; 70(8):929-48. PubMed ID: 20481652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients.
    Droemann D; Goldmann T; Tiedje T; Zabel P; Dalhoff K; Schaaf B
    Respir Res; 2005 Jul; 6(1):68. PubMed ID: 16004610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease].
    Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
    Kong YJ; Sun WX; Zhang YM; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.